Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (15 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
0
0
0
17
Research and development
2
5
23
76
General and administrative
1
1
14
44
Total operating expenses
3
6
37
121
Loss from operations
-3
-6
-37
-103
Interest income
0
0
0
2
Interest expense
0
0
-6
-1
Other income (expense)
0
0
0
1
Total other income (expense)
0
0
-6
2
Net loss
-3
-6
-43
-102
Series A preferred stock dividend
0
-1
-1
0
Net loss attributable to common stockholders
-3
-8
-44
-102
Net loss
-3
-6
-43
-102
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
22
209
393
Marketable securities
n/a
0
158
222
Prepaid expenses and other current assets
n/a
0
1
16
Total current assets
n/a
23
368
631
Restricted cash
n/a
0
0
2
Property and equipment, net
n/a
0
2
30
Intangible assets, net
n/a
0
0
11
Goodwill
n/a
0
0
25
Other assets
n/a
0
0
8
Total assets
n/a
23
371
708
Liabilities and owners' equity
Accounts payable
n/a
0 382000
2 2320000
8 8049000
Deferred revenue
n/a
0 0
0 0
16 16333000
Accrued expenses and other current liabilities
n/a
1 980000
4 4405000
12 11787000
Total current liabilities
n/a
1 1362000
7 6725000
36 36169000
Deferred revenue, less current portion
n/a
0 0
0 0
32 32176000
Contingent consideration
n/a
0 0
0 0
16 16080000
Other non-current liabilities
n/a
0 0
1 1439000
8 7778000
Deferred rent
n/a
0 39000
0 0
0 0
Total liabilities
n/a
1 1401000
8 8164000
92 92203000
Commitments and contingencies
n/a
0 0
0 0
0 0
Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2015 and December 31, 2014
n/a
0 0
0 0
0 0
Common stock, $0.001 par value, 200,000,000 shares authorized; 48,671,757 and 41,855,304 shares issued and outstanding, excluding 1,091,306 and 2,180,129 shares subject to repurcha
n/a
0 6000
0 42000
0 49000
Additional paid-in capital
n/a
37 36990000
421 420848000
776 775588000
Accumulated other comprehensive loss
n/a
0 0
0 -297000
0 -220000
Accumulated deficit
n/a
-15 -15435000
-58 -58004000
-160 -159657000
Total stockholders' equity
n/a
22 21581000
363 362589000
616 615760000
Total liabilities and stockholders' equity
n/a
23 22982000
371 370753000
708 707963000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Feb 29, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net loss
-3
-6
-43
-102
Depreciation and amortization
0
0
0
5
Stock-based compensation
0
0
16
40
Change in fair value of derivative liability
0
0
0
0
Noncash interest expense
0
0
6
0
Deferred rent
0
0
0
2
Other adjustments
0
0
0
0
Amortization of discount on marketable securities
0
0
0
1
Gain on adjustment of contingent consideration
0
0
0
-1
Deferred revenue
0
0
0
49
Prepaid expenses and other current assets
0
0
-1
-15
Other assets
0
0
0
-8
Accounts payable
0
0
2
5
Accrued expenses and other current liabilities
0
0
2
8
Due to related party
0
0
0
0
Net cash used in operating activities
-3
-6
-17
-16
Purchase of property and equipment
0
0
-2
-27
Purchases of marketable securities
0
0
-1,195
-222
Sales and maturities of marketable securities
0
0
1,037
157
Amounts used to secure facilities
0
0
0
-2
Net cash paid related to acquisition of T-Cell Factory, B.V.
0
0
0
-15
Net cash used in investing activities
0
0
-160
-108
Principal payments on capital lease obligations
0
0
0
0
Initial public offering costs
0
0
-24
0
Proceeds from issuance of common stock
0
0
335
301
Proceeds from exercise of stock options
0
0
3
7
Proceeds from issuance of preferred stock, net
0
20
0
0
Proceeds from issuance of convertible notes
0
0
50
0
Net cash provided by financing activities
0
20
364
308
Effect of exchange rate changes on cash
0
0
0
0
Net change in cash and cash equivalents
-3
14
187
184
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,